The Report"Biochips Market Size & Share by Type (DNA Chip (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip (IVD & POC, Proteomics), Protein Chips), Fabrication Technology (Microarrays, Microfluidics), End user (Academics Institutes, Diagnostics Centers) - Global Forecast to 2020".
[170 Pages Report] The overall biochips market size is estimated to grow at a CAGR of 18.4% from 2015 to 2020 to reach $17.75 billion by 2020.
The development of targeted and personalized medicines for the treatment of cancer and technological advancements in biochips are also supporting the growth of biochip products. The objective of Market report is to define, describe, and forecast the global market of biochips on the basis of type, applications, end user, and region. It provides detailed information regarding the major factors influencing the growth of overall market. Drivers, restraints, opportunities, challenges, and trends in the market have also been taken into consideration while preparing this report. This report also tracks and analyzes competitive developments of the key players in market in terms of market developments, product portfolios, and key financials.
Download a free pdf broucher @:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=54
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of various other dependent submarkets. The fabrication technology markets for all segments were determined through secondary research and were added up to obtain the global market value. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources.
This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Some of the secondary resources we referred are U.S. Food and Drug Administration, Journal of Biochips & Tissue Chips, American Medical Association (AMA), National Cancer Institute, Journal of Molecular Diagnostic and The World Bank.
Key Market Players
Key players in the biochips market include Abbott Laboratories (US), Agilent Technologies, Inc. (US), PerkinElmer Inc. (US), Fluidigm Corporation (US), Illumina, Inc. (US), GE Healthcare (US), Bio-Rad Laboratories Inc. (US), Cepheid Inc. (US), Thermo Fisher Scientific, Inc. (US), and F. Hoffmann-La Roche AG (Switzerland).
Speak to our Analyst @:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=54
[170 Pages Report] The overall biochips market size is estimated to grow at a CAGR of 18.4% from 2015 to 2020 to reach $17.75 billion by 2020.
The development of targeted and personalized medicines for the treatment of cancer and technological advancements in biochips are also supporting the growth of biochip products. The objective of Market report is to define, describe, and forecast the global market of biochips on the basis of type, applications, end user, and region. It provides detailed information regarding the major factors influencing the growth of overall market. Drivers, restraints, opportunities, challenges, and trends in the market have also been taken into consideration while preparing this report. This report also tracks and analyzes competitive developments of the key players in market in terms of market developments, product portfolios, and key financials.
Download a free pdf broucher @:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=54
 |
Top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of various other dependent submarkets. The fabrication technology markets for all segments were determined through secondary research and were added up to obtain the global market value. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources.
This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Some of the secondary resources we referred are U.S. Food and Drug Administration, Journal of Biochips & Tissue Chips, American Medical Association (AMA), National Cancer Institute, Journal of Molecular Diagnostic and The World Bank.
Key Market Players
Key players in the biochips market include Abbott Laboratories (US), Agilent Technologies, Inc. (US), PerkinElmer Inc. (US), Fluidigm Corporation (US), Illumina, Inc. (US), GE Healthcare (US), Bio-Rad Laboratories Inc. (US), Cepheid Inc. (US), Thermo Fisher Scientific, Inc. (US), and F. Hoffmann-La Roche AG (Switzerland).
Speak to our Analyst @:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=54
Comments
Post a Comment